Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Inhibitors of multiple leukotrienes in development for asthma at Czech research institute

June 23, 2000

BIIL-284: preclinical profile of a new, orally active LTB4 antagonist

June 23, 2000

Antiallergic agents from JT inhibit the production of IgE and IL-5

June 22, 2000

Three newly issued patents cover novel CCR3 receptor antagonists synthesized at SmithKline Beecham

June 21, 2000

New PDE4/TNF inhibitors with superior physicochemical and pharmacokinetic profile

June 19, 2000

Vitamin D3 derivatives synthesized at Teijin, particularly useful for airways diseases

June 19, 2000

Seretide MDI approved in the U.K. for asthma Rx

June 19, 2000

New NHLBI study to identify best treatment for mild persistent asthma

June 19, 2000

Benzoylpyridazines as PDE4 and TNF production inhibitors

June 16, 2000

Dompe prepares agents for the treatment of neutrophil-dependent pathologies

June 16, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...